Multiple dose escalation study in subjects with cancer indicated no accumulation for Cmax and 14% accumulation for AUC at dose 240 mg at steady state (n=3, day 21). In the expansion cohort of 320 mg at steady state (day 21, n=31), the accumulations were 1.2 and 1.5 for Cmax and AUC respectively (Table 55).